Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Avery RL, Pearlman J, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006; 113 (10): 1695.e1–1695.e15.
Avery RL . Regression of retinal and iris neovascularization after intravitreal bevacizumab (Avastin) treatment. Retina 2006; 26 (3): 352–354.
Isaacs TW, Barry C . Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab (Avastin). Clin Experiment Ophthalmol 2006; 34 (8): 802–803.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tranos, P., Gemenetzi, M., Papandroudis, A. et al. Progression of diabetic tractional retinal detachment following single injection of intravitreal Avastin. Eye 22, 862 (2008). https://doi.org/10.1038/sj.eye.6703036
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.eye.6703036
This article is cited by
-
Pre-operative intravitreal bevacizumab for tractional retinal detachment secondary to proliferative diabetic retinopathy: the Alvaro Rodriguez lecture 2023
International Journal of Retina and Vitreous (2023)
-
Use of pegaptanib for recurrent and non-clearing vitreous haemorrhage in proliferative diabetic retinopathy
Eye (2010)
-
Intravitreal pegaptanib in severe proliferative diabetic retinopathy leading to the progression of tractional retinal detachment
Eye (2009)
